+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Celiac Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Endometriosis- Pipeline Insight, 2025 - Product Thumbnail Image

Endometriosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Pemphigus Vulgaris - Pipeline Insight, 2025 - Product Thumbnail Image

Pemphigus Vulgaris - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sleep Apnea - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sarcopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Sarcopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Myositis - Pipeline Insight, 2025 - Product Thumbnail Image

Myositis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Parkinson's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Parkinson's Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Bardet-Biedl Syndrome - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Bardet-Biedl Syndrome - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
Asthma - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Asthma - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
Drug Resistant Epilepsy - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Drug Resistant Epilepsy - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
Alpha Thalassemia - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Alpha Thalassemia - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 400 Pages
  • Global
From
JAK Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

JAK Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Glaucoma - Competitive Landscape, 2026 - Product Thumbnail Image

Glaucoma - Competitive Landscape, 2026

  • Report
  • January 2026
  • 280 Pages
  • Global
From
Chronic Kidney Disease - Competitive Landscape, 2026 - Product Thumbnail Image

Chronic Kidney Disease - Competitive Landscape, 2026

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Asthma - Competitive Landscape, 2026 - Product Thumbnail Image

Asthma - Competitive Landscape, 2026

  • Report
  • January 2026
  • 240 Pages
  • Global
From
Atopic Dermatitis - Competitive Landscape, 2026 - Product Thumbnail Image

Atopic Dermatitis - Competitive Landscape, 2026

  • Report
  • January 2026
  • 240 Pages
  • Global
From
Monoclonal Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Monoclonal Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
Sickle Cell Disease - Competitive Landscape, 2026 - Product Thumbnail Image

Sickle Cell Disease - Competitive Landscape, 2026

  • Report
  • January 2026
  • 196 Pages
  • Global
From
HSV-1 Keratitis - Competitive Landscape, 2026 - Product Thumbnail Image

HSV-1 Keratitis - Competitive Landscape, 2026

  • Report
  • January 2026
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more